BiotechTubeBiotechTube
Home/Dyve Biosciences/Camilla Simpson
CS

Camilla Simpson

Board Member

Dyve Biosciences

Therapeutic Areas

OncologyImmunologyRheumatology

Dyve Biosciences Pipeline

DrugIndicationPhase
DYV800Solid Tumors (Oncology)Phase 2
DYV700Acute Gouty ArthritisPhase 2
DMAX PlatformBroad (Immunologic & Oncologic Diseases)Platform

Leadership Team at Dyve Biosciences

RB
Ryan Beal
Chief Executive Officer, Board Member
RM
Rajit Malhotra
Executive Chairman of the Board
PS
Philippe Schaison
Board Member
TB
Tatyana Beldock
Board Member
View full Dyve Biosciences profile